Preliminary Suggestion about Staging of Anorectal Malignant Melanoma May Be Used to Predict Prognosis
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose Anorectal malignant melanomas (AMM) are rare and have poor survival. The study aims to evaluate the clinicopathologic characteristics and outcomes of patients with AMM, and to devise a staging system predictive of survival outcome. Materials and Methods This was a retrospective study of 28 patients diagnosed with, and treated for AMM. Patients classified by clinical staging of mucosal melanoma (MM) were reclassified via rectal and anal TNM staging. Survival outcomes were compared among patients grouped by the three different staging systems. Results The three staging systems were equated with similar figures for 5-year overall survival (OS) and 5-year disease-free survival (DFS) of patients diagnosed with stage I disease. Patients (n=19) diagnosed with MM stage II disease were reclassified by rectal TNM staging into three subgroups: IIIA, IIIB, and IIIC. For these patients, both 5-year OS and 5-year DFS differed significantly between the subgroups IIIA and IIIC (OS: IIIA vs. IIIC, 66.7% vs. 0%, p=0.002; DFS: IIIA vs. IIIC, 51.4% vs. 0%, p < 0.001). Conclusion The accuracy of prognosis in patients diagnosed with AMM and lymph node metastasis has improved by using rectal TNM staging, which includes information regarding the number of lymph node metastases.
Abstract
Purpose Anorectal malignant melanomas (AMM) are rare and have poor survival. The study aims to evaluate the clinicopathologic characteristics and outcomes of patients with AMM, and to devise a staging system predictive of survival outcome. Materials and Methods This was a retrospective study of 28 patients diagnosed with, and treated for AMM. Patients classified by clinical staging of mucosal melanoma (MM) were reclassified via rectal and anal TNM staging. Survival outcomes were compared among patients grouped by the three different staging systems. Results The three staging systems were equated with similar figures for 5-year overall survival (OS) and 5-year disease-free survival (DFS) of patients diagnosed with stage I disease. Patients (n=19) diagnosed with MM stage II disease were reclassified by rectal TNM staging into three subgroups: IIIA, IIIB, and IIIC. For these patients, both 5-year OS and 5-year DFS differed significantly between the subgroups IIIA and IIIC (OS: IIIA vs. IIIC, 66.7% vs. 0%, p=0.002; DFS: IIIA vs. IIIC, 51.4% vs. 0%, p < 0.001). Conclusion The accuracy of prognosis in patients diagnosed with AMM and lymph node metastasis has improved by using rectal TNM staging, which includes information regarding the number of lymph node metastases.
참고문헌 (24)
- Belbaraka R, "Management of anorectal melanoma : report of 17 cases and literature review", J Gastrointest Cancer, 43, pp.31~35 (2012)
- Chang AE, "The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society", Cancer, 83, pp.1664~1678 (1998)
- Falch C, "Anorectal malignant melanoma : extensive 45-year review and proposal for a novel staging classification", J Am Coll Surg, 217, pp.324~335 (2013)
- Banerjee SS, "Morphological and immunophenotypic variations in malignant melanoma", Histopathology, 36, pp.387~402 (2000)
- Roumen RM, "Anorectal melanoma in The Netherlands : a report of 63 patients", Eur J Surg Oncol, 22, pp.598~601 (1996)
- Kubo K, "Lack of association of Borna disease virus and human T-cell leukemia virus type 1 infections with psychiatric disorders among Japanese patients", Clin Diagn Lab Immunol, 4, pp.189~194 (1997)
- Iddings DM, "Practice patterns and outcomes for anorectal melanoma in the USA, reviewing three decades of treatment : is more extensive surgical resection beneficial in all patients?", Ann Surg Oncol, 17, pp.40~44 (2010)
- Talsma K, "Comparison of the 6th and 7th Editions of the UICC-AJCC TNM Classification for Esophageal Cancer", Ann Surg Oncol, pp.2142~2148 (2012)
- Ward MW, "The surgical treatment of anorectal malignant melanoma", Br J Surg, 73, pp.68~69 (1986)
- Antoniuk PM, "Anorectal malignant melanoma has a poor prognosis", Int J Colorectal Dis, 8, pp.81~86 (1993)
- Ishizone S, "Surgical treatment for anorectal malignant melanoma : report of five cases and review of 79 Japanese cases", Int J Colorectal Dis, 23, pp.1257~1262 (2008)
- Nilsson PJ, "Importance of clear resection margins in anorectal malignant melanoma", Br J Surg, 97, pp.98~103 (2010)
- Podnos YD, "Factors affecting survival in patients with anal melanoma", Am Surg, 72, pp.917~920 (2006)
- Cagir B, "Changing epidemiology of anorectal melanoma", Dis Colon Rectum, 42, pp.1203~1208 (1999)
- Luna-Perez P, "Anorectal malignant melanoma", Surg Oncol, 5, pp.165~168 (1996)
- Weinstock MA, "Epidemiology and prognosis of anorectal melanoma", Gastroenterology, 104, pp.174~178 (1993)
- Ben-Izhak O, "Anorectal malignant melanoma. A clinicopathologic study, including immunohistochemistry and DNA flow cytometry", Cancer, 79, pp.18~25 (1997)
- Goldman S, "Anorectal malignant melanoma in Sweden. Report of 49 patients", Dis Colon Rectum, 33, pp.874~877 (1990)
- Cooper PH, "Malignant melanoma of the anus : report of 12 patients and analysis of 255 additional cases", Dis Colon Rectum, 25, pp.693~703 (1982)
- Pessaux P, "Surgical management of primary anorectal melanoma", Br J Surg, 91, pp.1183~1187 (2004)
- Brady MS, "Anorectal melanoma. A 64-year experience at Memorial Sloan-Kettering Cancer Center", Dis Colon Rectum, 38, pp.146~151 (1995)
- Yap LB, "A comparison of wide local excision with abdominoperineal resection in anorectal melanoma", Melanoma Res, 14, pp.147~150 (2004)
- Bullard KM, "Surgical therapy for anorectal melanoma", J Am Coll Surg, 196, pp.206~211 (2003)
- Bujko K, "Radiation therapy for anorectal melanoma : a report of three cases", Acta Oncol, 37, pp.497~499 (1998)